Work

A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors

Year: 2019

Type: article

Study design: Clinical Trial

Source: Targeted Oncology

DOI: 10.1007/s11523-019-00661-5

Authors: Thomas B. Karasic, E. Gabriela Chiorean, Said M. Sebti, Peter J. O’Dwyer

Institutions: University of Pennsylvania, University of Washington, Moffitt Cancer Center

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Moffitt Cancer Center Support Grant

OpenAlex ID: W2964857152

FWCI: 2.067

Cites: 12

Cited by: 51

Related to: 10